Who should have genetic testing for maturity‐onset diabetes of the young?
- 7 September 2011
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 75 (4), 422-426
- https://doi.org/10.1111/j.1365-2265.2011.04049.x
Abstract
Maturity-onset diabetes of the young (MODY) is a clinically heterogeneous group of monogenic disorders characterized by autosomal dominant inheritance of young-onset, non-insulin-dependent diabetes. The genes involved are important in beta cell development, function and regulation and lead to disorders in glucose sensing and insulin secretion. Heterozygous GCK mutations cause impaired glucokinase activity resulting in stable, mild hyperglycaemia that rarely requires treatment. HNF1A mutations cause a progressive insulin secretory defect that is sensitive to sulphonylureas, most often resulting in improved glycaemic control compared with other diabetes treatment. MODY owing to mutations in the HNF4A gene results in a similar phenotype, including sensitivity to sulphonylurea treatment. HNF1B mutations most frequently cause developmental renal disease (particularly renal cysts) but may also cause MODY in isolation or may cause the renal cysts and diabetes syndrome (RCAD syndrome). Mutations in NEUROD1, PDX1 (IPF1), CEL and INS are rare causes of MODY. MODY is often misdiagnosed as type 1 or type 2 diabetes. However, a correct genetic diagnosis impacts treatment and identifies at-risk family members. Thus, it is important to consider a diagnosis of MODY in appropriate individuals and to pursue genetic testing to establish a molecular diagnosis.Keywords
This publication has 30 references indexed in Scilit:
- Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1-α/Hepatocyte Nuclear Factor 4-α Maturity-Onset Diabetes of the Young From Long-Duration Type 1 DiabetesDiabetes Care, 2011
- Assessment of High-Sensitivity C-Reactive Protein Levels as Diagnostic Discriminator of Maturity-Onset Diabetes of the Young Due to HNF1A MutationsDiabetes Care, 2010
- Mutations in the VNTR of the carboxyl-ester lipase gene (CEL) are a rare cause of monogenic diabetesHuman Genetics, 2009
- Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetesDiabetes & Metabolism, 2009
- A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin‐treated patientsDiabetic Medicine, 2009
- Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutationDiabetic Medicine, 2009
- Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the youngDiabetologia, 2008
- Macrosomia and Hyperinsulinaemic Hypoglycaemia in Patients with Heterozygous Mutations in the HNF4A GenePLoS Medicine, 2007
- Mutations in hepatocyte nuclear factor-1 and their related phenotypesJournal of Medical Genetics, 2005
- Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune type 1 diabetes in children older than 3 yr of agePediatric Diabetes, 2002